These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Nuclear binding of steroid-receptor complex to lymphosarcoma P1798 resistant and sensitive cells and effect of concanavalin A on receptor levels.
    Author: McPartland RP, Milholland RJ, Rosen F.
    Journal: Cancer Res; 1977 Dec; 37(12):4256-60. PubMed ID: 579163.
    Abstract:
    Glucocorticoid-resistant P1798 cell lines have been found to contain levels of glucocorticoid receptor comparable to receptor levels in glucocorticoid-sensitive P1798 cells. Previously, most of the P1798 resistant cells examined were found to contain low levels of glucocorticoid receptor, and this was thought to account for the resistance of these cells to glucocorticoid treatment. Resistant cells with high receptor levels exhibited 10 to 50 percent lower levels of nuclear binding than did sensitive cells. In addition, 90 percent of the glucocorticoid-receptor complex could be extracted from resistant nuclei with 0.2 M NaCl, while only 55 percent of the complex could be extracted from sensitive nuclei, indicating that the affinity of the hormone-receptor complex for resistant nuclei may be weaker than the affinity of the hormone-receptor complex for sensitive nuclei. The effect of concanavalin A was also examined in P1798 sensitive and resistant cells. Concanavalin A effectively lowered glucocorticoid receptor levels in the sensitive cells by 45 percent, while receptor levels of the resistant cells were only slightly lowered. The effect of concanavalin A was both temperature dependent (effective at 37 degrees but not 0 degrees) and time dependent. Thus glucocorticoid resistance of P1798 cells appears to have a more complex mechanism than previously proposed.
    [Abstract] [Full Text] [Related] [New Search]